Helicobacter pylori and the pathogenesis of gastroduodenal inflammation

Journal of Infectious Diseases

Volumn 161, Issue 4, 1990, Pages 626-633

  Blaser, Martin J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANTIBIOTIC THERAPY; BACTERIAL VIRULENCE; BACTERIUM CLEARANCE; CONFERENCE PAPER; DISEASE ASSOCIATION; DUODENUM ULCER; EXPERIMENTAL INFECTION; GASTRITIS; GASTROINTESTINAL DISEASE; HELICOBACTER PYLORI; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SWINE; TISSUE SPECIFICITY;

ANIMAL; CAMPYLOBACTER; CAMPYLOBACTER INFECTIONS; DUODENAL ULCER; DUODENITIS; GASTRITIS; HUMAN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; VIRULENCE;

EID: 0025349492     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/161.4.626     Document Type: Article

References (69)

1. Strickland R.G., Mackay I.R. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis 1973;18:426–440
2. Pauli G., Yardley J.H. Pathology of C. pylori–associated gastric and esophageal lesions. In: Blaser MJ, ed. Campylobacter pylori in gastritis and peptic ulcer disease. New York: Igaku Shoin Medical Publishers, 1989:73–98
3. Dooley C.P., Fitzgibbons P.L., Cohen H., Appleman M.D., Perez-Perez G.I., Blaser M.J. Prevalence of Campylobacter pylori infection and histologic gastritis in asymptomatic persons–correlation with gastric and duodenal inflammation. N Engl J Med 1989;321:1562–1566
4. Kekki M., Villako K., Tamm A., Siurala M. Dynamics of antral and fundal gastritis in an Estonian rural population sample. Scand J Gastroenterol 1977;12:321–324
5. Siurala M., Isokoski M., Varis K., Kekki M. Prevalence of gastritis in a rural population. Bioptic study of subjects selected at random. Scand J Gastroenterol 1968;3:211–223
6. Siurala M., Varis K., Wiljasalo M. Studies of patients with atrophic gastritis: A 10–15 year follow–up. Scand J Gastroenterol 1966;1:40–48
7. Wyatt J.I., Rathbone B.J., Dixon M.F., Heatley R.V. Campylobacterpyloridis and acid–induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol 1987;40:841–848
8. Greenlaw R., Sheahan D.G., DeLuca V., Miller D., Myerson D., Myerson P. Gastroduodenitis: A broader concept of peptic ulcer disease. Dig Dis Sci 1980;660–672
9. Warren J.R., Marshall B.J. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;2:1273–1275
10. Marshall B.J. History of the discovery of Campylobacter pylori. In: Blaser MJ, ed. Campylobacter pylori in gastritis and peptic ulcer disease. New York: Igaku Shoin Medical Publishers, 1989:7–23
11. Goodwin C.S., Armstrong J.A., Chilvers T., Peters M., Collins M.D., Sly L., McConnell W., Harper W.E.S. Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb, nov., respectively. Int J Syst Bacteriol 1989;39:397–405
12. 13C–urea breath test. Lancet 1987;1:1174–1177
13. Petez-Perez G.I., Dworkin B., Chodos J., Blaser M.J. Campylobacter pylori–specific serum antibodies in humans. Ann Intern Med 1988; 109:11–17
14. Marshall B.J., Warren J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;1:1311–1313
15. Carrick J., Lee A., Hazell S., Ralston M., Daskalopoulos G. Campylobacter pylori, duodenal ulcer, and gastric metaplasia: Possible role of functional heterotropic tissue in ulcerogenesis. Gut 1989;30:790–797
16. Johnston B.J., Reed P.I., Ali M.H. Campylobacter–like organisms in duo denal and antral endoscopic biopsies: Relationship to inflammation. Gut 1986;27:1132–1137
17. Langenberg W., Rauws E.A.J., Wtdjojokusumo A., Tytgat G.N.J., Zanen H.C. Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis. J Clin Microbiol 1986;24:414–417
18. Kosunen T.U., Hook J., Rautelin H.I., Myllyla G. Age–dependent increase of Campylobacter pylori antibodies in blood donors. Scand J Gastroenterol 1989;24:110–114
19. Polish L.B., Douglas J.M., Davidson A.J., Le Y.K., Perez-Perez G.I., Blaser M.J. Eflect of ethnicity, sexual preference and HIV antibody status on Campylobacter pylori seroprevalence [abstract 1014]. In: Program and abstracts of the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC: American Society for Microbiology, 1989
20. Megraud F., Brassens-Rabbe M.P., Denis F., Belbouri A., Hoa D.Q. Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol 1989;27:1870–1873
21. Buck G.E., Gourley W.K., Lee W.K., Subramanyam K., Latimer J.M., DiNuzzo A.R. Relation of Campylobacter pyloridis to gastritis and peptic ulcer. J Infect Dis 1986;153:664–669.
22. Goodwin C.S., Armstrong J.A., Marshall B.J. Campylobacter pyloridis gastritis and peptic ulceration. J Clin Pathol 1986;39:353–365
23. Drumm B., Sherman P., Cutz E., Karmali M. Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children. N Engl J Med 1987;316:1557–1561
24. O’Connor H.J., Axon A.T.R., Dixon M.F. Campylobacter–WYe organisms unusual in type A (pernicious anaemia) gastritis. Lancet 1984;2:1091
25. Jaun D.G., Sancho F.J., Sainz S., Such J., Fernandez M., Xiol J.M. Cam pylobacter pylori and pernicious anaemia [letter]. Lancet 1988;1:57
26. O’Connor H.J., Wyatt J.I., Dixon M.F., Axon A.T.R. Campylobacter–like organisms and reflux gastritis. J Clin Pathol 1986;39:531–534
27. Evans D.J. Jr, Evans D.G., Graham D.Y., Klein P.D. A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology 1989;96:1004–1008
28. Morris A., Maher K., Thomsen L., Miller M., Nicholson G., Tasman–Jones Distribution of Campylobacter pylori in the human stomach obtained at postmortem. Scand J Gastroenterol 1988;23:257–264
29. McNulty C.A.M., Gearty J.C., Crump B., Davis M., Donovan I.A., Melikian V., Lister D.M., Wise R. Campylobacter pyloridis and associated gastritis: Investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. Br Med J [Clin Res] 1986; 293:645–649
30. Rauws E.A.J., Langenberg W., Houthoff H.J., Zanen H.C., Tytgat GNJ. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988;94:33–40
31. Marshall B.J., Goodwin C.S., Warren J.R., Blincow E.D., Phillips M., Good win C.S., Murray R., Blackburn S.J., Waters T.E., Sanderson C.R. Prospective double–blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;2:1437–1445
32. Gastrointestinal Physiology Working Group of Cayetano Heredia and the Johns Hopkins Universities, Morgan D, Kraft W, Bender M, Pearson A. Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. Gastroenterology 1988;95:1178–1184
33. Glupczynski Y., Burette A., Labbe M., Dereuck M., Deltenre M. Campylobacter pylori–associated gastritis: A double blind, placebo-controlled trial with amoxicillin. Am J Gastroenterol 1988;83:365–372
34. Bonilla J., Gilman R.H., Ramirez-Ramos A., Rodriquez C., Leon-Barua R., Recavarren S., Guebarra C., Watanabae J., Cok J., Spira W.M. Tetracycline in the treatment of gastritis associated with Campylobacter pylori [abstract 43]. In: Program and abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1988
35. Vaira D., Holton J., Cairns S.R., Falzon M., Polydorou A., Dowsett J.F., Salmon P.R. Antibody titers to Campylobacter pylori after treatment for gastritis. Br Med J [Clin Res] 1988;297:397
36. Oderda G., Vaira D., Holton J., Ainley C., Altare F., Ansaldi N. Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: Assessment by serum IgG antibody, pepsinogen 1, and gastrin levels. Lancet 1989;1:690–692
37. VanBohemen C.G., Langenberg M.L., Rauws E.A.J., Oudbier J., Weterings E., Zanen H.C. Rapidly decreased serum IgG to Campylobacter pylori following elimination of Campylobacter in histological chronic biopsy Campylobacter-positive gastritis. Immunol Lett 1989;20:59–62
38. Marshall B.J., Armstrong J.A., McGechie D.B., Glancy R.J. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust 1985; 142:436–439
39. Morris A., Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987; 82:192–199
40. Morris A., Nicholson G. Experimental and accidental C. pylori infection of humans. In: Blaser MJ, ed. Campylobacter pylori in gastritis and peptic ulcer disease. New York: Igaku Shoin Medical Publishers, 1989:61–72
41. Gledhill T., Leicester R.J., Addis B., Lightfoot N., Barnard J., Viney N., Darkin D. Hunt R.H. Epidemic hypochlorhydria. Br Med J [Clin Res] 1985;290:1383–1386
42. Ramsey E.J., Carey K.V., Peterson W.L., Jackson J.J.J., Murphy F.K., Read N.W., Taylor K.B., Trier J.S., Fordtran J.S. Epidemic gastritis with hypochlorhydria. Gastroenterology 1979;76:1449–1457
43. Peterson W., Lee E., Skoglund M. The role of Campylobacter pyloridis in epidemic gastritis with hypochlorhydria [abstract]. Gastroenterology 1987;92:1575
44. Krakowka S., Morgan D.P., Kraft W.G., Leunk R.D. Establishment of gastric Campylobacter pylori infection in the neonatal gnotobiotic piglet. Infect Immun 1987;55:2789–2796
45. Lambert J.R., Borromeo M., Pinkard K.J., Turner H., Chapman C.B., Smith M.L. Colonization of gnotobiotic piglets with Campylobacter pyloridis–an animal model? [letter]. J Infect Dis 1987;155:1344
46. Tricottet V., Bruneval P., Vire O., Camilleri J.P. Campylobacter-like organisms and surface epithelium abnormalities in active, chronic gastritis in humans: An ultrastructural study. Ultrastruct Pathol 1986; 10:113–122
47. Krakowa S., Eaton K.A., Morgan D.R. Campylobacter pylori gastritis ingnotobiotic piglets: Persistence of gastric infection after conventionalization [abstract 180], In: Program and abstracts of the fifth international workshop on Campylobacter infections (Puerto Vallarta, Mexico). Mexico City: Institute Nacional de la Nutricion, 1989
48. Chen X.G., Correa P., Oflerhaus J., Rodriquez E., Janney F., Hoffmann E., Fox J., Hunter F., Diaviolitsis S. Ultrastructure of the gastric mucosa harboring Campylobacter–like organisms. Am J Clin Pathol 1986; 86:575–582
49. Hazell S.L., Lee A., Brady L., Hennessy W. Campylobacterpyloridis and gastritis: Association with intracellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis 1986;153:658–663
50. Eaton K.A., Morgan D.R., Krakowka S. Campylobacter pylori virulence factors in gnotobiotic piglets. Infect Immun 1989;57:1119–1125
51. Evans D.G., Evans D.J., Moulds J.J., Graham D.Y. N–acetylneuraminyllactosebinding fibrillar hemagglutinin of Campylobacter pylori: A putative colonization factor antigen. Infect Immun 1988;56:2896–2906
52. Fauchere J.L., Blaser M.J. Simplified determination of Campylobacter pylori adherence to epithelial cells by microtiter enzyme assays [abstract]. In: Proceedings of the 89th annual meeting of the American Society of Microbiology. Washington, DC: American Society for Microbiology, 1989
53. Dunn B.E., Campbell G., Perez-Perez G.I., Blaser M.J. Purification and characterization of Campylobacter pylori urease [abstract 344]. In: Program and abstracts of the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1989
54. Marshall B.J., Barrett U., Guerrant R.L. Protection of Campylobacter pyloridis [Cp] but not Campylobacter jejuni [Cj] against acid susceptibility by urea [abstract 38]. In: Proceedings of the fourth international workshop on Campylobacter infections (Goteborg, Sweden). Gotebotg: University of Goteborg, 1987
55. Ferrero R.L., Hazell S.L., Lee A. The urease enzymes of Campylobacter pylori and a related bacterium. J Med Microbiol 1988;27:33–40.
56. Leunk R.D., Johnson P.T., David B.C., Kraft W.G., Morgan D.R. Cytotoxic activity in broth culture filtrates of Campylobacter pylori. J Med Microbiol 1988;26:93–99
57. Simor A., Leunk R.D., Low D., Gregson D., Morgan D. Correlation between antibacterial and antitoxin antibodies and Campylobacter pylori infection [abstract 199]. In: Program and abstracts of the fifth international workshop on Campylobacter infections (Puerto Vallarta, Mexico). Mexico City: Instituto Nacional de la Nutricion, 1989
58. Cover T.L., Dooley C.P., Blaser M.J. Characterization and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun (in press)
59. Slomiany B.L., Bilsky J., Sarosiek J., Murty V.L.N., Dworkin B., VanHorn K., Zielenski J., Slomiany A. Campylobacter pyloridis degrades mucin and undermines gastric mucosal integrity. Biochem Biophys Res Commun 1987;144:307–312
60. Crabtree J.E., Rathbone B.J., Heatley R.V., Wyatt J.I., Losowsky M.S. In vitroglycoprotein synthesis and secretion in Campylobacter pyloridis-as- sociated chronic gastritis [abstract 38]. In: Proceedings of the fourth international workshop on Campylobacter infections (Goteborg, Sweden). Goteborg: University of Goteborg, 1987
61. Cave D.R., Vargas M. Effect of a Campylobacter pylori protein on acid secretion by parietal cells. Lancet 1989;2:187–189
62. James A.H. Gastric epithelium in the duodenum. Gut 1964;5:285–294
63. Rhodes J. Experimental production of gastric epithelium in the duode num. Gut 1964;5:454–458.
64. Moigan D.R., Leunk R.D. Pathogenesis of infection by C. pylori. In: Blaser MJ, ed. Campylobacter pylori in gastritis and peptic ulcer disease. New York: Igaku Shoin Medical Publishers, 1989:115–133
65. Blaser M.J., Lindenbaum J., Perez-Perez G.I., Van Derenter G., Schneid man D., Weinstein W.M. Association of Campylobacter pylori with specific upper gastrointestinal pathology [abstract 197]. In: Program and abstracts of the fifth international workshop on Campylobacter infections (Puerto Vallarta, Mexico). Mexico City: Instituto Nacional de la Nutricion, 1989
66. Figura N., Guglielmetti P., Rossolini A., Barberi A., Cusi G., Musmanno R.A., Russi M., Quaranta S. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989;27:225–226
67. Coghlan J.G., Gilligan D., Humphries H., McKenna D., Dooley C., Sweeney E., Keane C., O’Morain C. Campylobacter pylori and recurrence of duodenal ulcers–a 12–month follow–up study. Lancet 1987;2:1109–1111
68. Goodwin C.S., Blake P., Blincow E. The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis. J Antimicrob Chemother 1986;17:309–314
69. Brown W.R. Treatment of inflammatory gastroduodenal illness: Gastnoen terologic viewpoint. In: Blaser MJ, ed. Campylobacter pylori in gastritis and peptic ulcer disease. New Ifork: Igaku Shoin Medical Publishers, 1989:209–224